Technological disruption is the primary engine fueling the Cancer Immunotherapy Market growth, with gene-editing technologies like CRISPR becoming instrumental in the design of next-generation therapies. These tools allow scientists to modify immune cells with unprecedented precision, creating "super-cells" capable of targeting tumors that were previously considered treatment-resistant. This...
Bangla